Vestibular Function Outcome After Cartilage Cap Occlusion Surgery
This study is currently recruiting participants.
Verified November 2012 by Mayo Clinic
Sponsor:
Mayo Clinic
Information provided by (Responsible Party):
Larry B. Lundy, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01727544
First received: August 22, 2012
Last updated: November 12, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary objective of this study is to measure objective, functional outcomes of patients undergoing cartilage cap occlusion surgery for a dehiscent superior semicircular canal.
| Condition | Intervention | Phase |
|---|---|---|
|
Vestibular Dizziness Superior Semicircular Canal Dehiscence |
Procedure: cartilage cap occlusion surgery |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Objective Assessment of Vestibular Function Outcome After Cartilage Cap Occlusion Surgery for Dehiscent Superior Semicircular Canal |
Resource links provided by NLM:
Further study details as provided by Mayo Clinic:
Primary Outcome Measures:
- objective improvement [ Time Frame: baseline to 3 months ] [ Designated as safety issue: Yes ]The primary outcome measure will be the subsequent (3 month) FGA scores between the control group and the surgery group to assess any objective improvement attributable to surgery
Secondary Outcome Measures:
- ABC Scale [ Time Frame: baseline to 3 months ] [ Designated as safety issue: No ]Secondary objective outcome measures will be changes in conductive hearing loss and changes in cervical VEMP thresholds between the two groups at the 3-month interval. Secondary subjective outcome measures will be ABC Scale and VAS scores between the two groups at 3 months.
- VAS scores [ Time Frame: baseline to 3 months ] [ Designated as safety issue: No ]Secondary objective outcome measures will be changes in conductive hearing loss and changes in cervical VEMP thresholds between the two groups at the 3-month interval. Secondary subjective outcome measures will be ABC Scale and VAS scores between the two groups at 3 months.
| Estimated Enrollment: | 64 |
| Study Start Date: | August 2012 |
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Surgical Group
patients will undergo a primary transmastoid and tegmen mini-craniotomy cartilage cap occlusion surgery.
|
Procedure: cartilage cap occlusion surgery
placement of a cartilage cap over the dome of the superior semicircular canal through a combined transmastoid and tegmen mini- craniotomy approach.
|
|
No Intervention: Non Surgical Group
patients meet the same criteria but will elect not to undergo surgery
|
Detailed Description:
One option for managing a dehiscent superior semicircular canal is surgical intervention. One of the surgical techniques is the transmastoid and tegmen mini-craniotomy cartilage cap occlusion of the dehiscent superior semicircular canal.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- ambulatory
- independent self-sufficient adults
- good general health
- medically stable
Exclusion Criteria:
- Medically unstable
- pregnant
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01727544
Contacts
| Contact: Shannon Kennedy | 904-953-7439 | kennedy.shannon@mayo.edu |
Locations
| United States, Florida | |
| Mayo Clinic in Florida | Recruiting |
| Jacksonville, Florida, United States, 32224 | |
| Contact: Shannon Kennedy 904-953-7439 kennedy.shannon@mayo.edu | |
Sponsors and Collaborators
Mayo Clinic
Investigators
| Principal Investigator: | Larry Lundy, MD | Mayo Clinic |
More Information
No publications provided
| Responsible Party: | Larry B. Lundy, PI, Mayo Clinic |
| ClinicalTrials.gov Identifier: | NCT01727544 History of Changes |
| Other Study ID Numbers: | 12-001953 |
| Study First Received: | August 22, 2012 |
| Last Updated: | November 12, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Mayo Clinic:
|
superior semicircular canal non-vestibular dizziness vestibular dizziness |
Additional relevant MeSH terms:
|
Dizziness Vertigo Sensation Disorders Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Vestibular Diseases Labyrinth Diseases Ear Diseases Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013